secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2024-08-23T23:59:59+00:00
Accession:  0001493152-24-033731
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences receives Nasdaq delisting notice for equity shortfall
-------------------------------------------------------------------------

- Notice received August 20, 2024; non-compliance with $2.5 million stockholders' equity minimum as of June 30, 2024.
- Company plans to timely request a hearing before the Nasdaq Hearings Panel, which will stay delisting action.
- No assurance that the Panel will grant continued listing or that compliance can be shown before any extension expires.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224033731/0001493152-24-033731-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224033731/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-033731

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer